Pexastimogene devacirepvec

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Pexastimogene devacirepvec
Accession Number
DB15069
Type
Biotech
Groups
Investigational
Description

Pexastimogene devacirepvec is under investigation in clinical trial NCT00429312 (A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma).

Synonyms
Not Available
External IDs
JX-594
Categories
Not Available
UNII
K82DG47I0G
CAS number
1058624-46-6

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Pexastimogene_devacirepvec

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedTreatmentCarcinoma, Colorectal2
1CompletedTreatmentEwing's Sarcoma (ES) / Malignant Lymphomas / Neuroblastomas / Rhabdomyosarcomas / Wilms' tumor1
1CompletedTreatmentLung Cancers / Melanoma / Renal Cell Adenocarcinoma / Squamous Cell Carcinoma of the Head and Neck (SCCHN)1
1RecruitingTreatmentAdvanced Tumor / Metastatic Tumors1
1RecruitingTreatmentRenal Cell Adenocarcinoma1
1, 2Active Not RecruitingTreatmentHepatocellular Carcinoma (HCC)1
1, 2CompletedTreatmentCarcinoma, Colorectal / CRC1
1, 2CompletedTreatmentMelanoma1
1, 2RecruitingTreatmentCancer, Breast / Soft-Tissue Sarcoma / Tumors, Solid1
2CompletedTreatmentHCC / Hepatocellular,Carcinoma / Liver Cancer1
2CompletedTreatmentHepatocellular Carinoma1
2CompletedTreatmentHepatocellular,Carcinoma1
2TerminatedTreatmentCarcinoma, Colorectal1
2WithdrawnTreatmentCancer of the Ovary1
3Active Not RecruitingTreatmentHepatocellular Carcinoma (HCC)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 08:46 / Updated on September 02, 2019 20:26